Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Paromomycin Cream for Bolivian Cutaneous Leishmaniasis
NCT03096457Phase 3Completed
- Sponsor
- Fundación Nacional de Dermatología
- Start
- Apr 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paromomycin in cutaneous leishmaniasis (CL), sponsored by Fundación Nacional de Dermatología. Started Apr 2017; status: completed.
02
Drugs
paromomycin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT03096457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096457.